NCT06655831View on ClinicalTrials.gov

Key Mechanisms of Abnormal T Cell Activation and Differentiation in IgG4-Related Ophthalmic Disease

Not yet recruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

January 1, 2025

Study Completion Date

February 1, 2025

Conditions
IgG4-Related Diseases
All Listed Sponsors
lead

Peking University Third Hospital

OTHER

NCT06655831 - Key Mechanisms of Abnormal T Cell Activation and Differentiation in IgG4-Related Ophthalmic Disease | Biotech Hunter | Biotech Hunter